The rs1458038 variant near FGF5 is associated with poor response to calcium channel blockers among Filipinos
- PMID: 35119014
- PMCID: PMC8812666
- DOI: 10.1097/MD.0000000000028703
The rs1458038 variant near FGF5 is associated with poor response to calcium channel blockers among Filipinos
Abstract
Genetic variation is known to affect response to calcium channel blockers (CCBs) among different populations. This study aimed to determine the genetic variations associated with poor response to this class of antihypertensive drugs among Filipinos.One hundred eighty one hypertensive participants on CCBs therapy were included in an unmatched case-control study. Genomic deoxyribonucleic acid were extracted and genotyped for selected genetic variants. Regression analysis was used to determine the association of genetic and clinical variables with poor response to medication.The variant rs1458038 near fibroblast growth factor 5 gene showed significant association with poor blood pressure-lowering response based on additive effect (CT genotype: adjusted OR 3.41, P = .001; TT genotype: adjusted OR 6.72, P < .001).These findings suggest that blood pressure response to calcium channels blockers among Filipinos with hypertension is associated with gene variant rs1458038 near fibroblast growth factor 5 gene. Further studies are recommended to validate such relationship of the variant to the CCB response.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interests to disclose.
Figures
References
-
- Forouzanfar MH, Liu P, Roth G. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 2017;317:165–82. - PubMed
-
- Food and Nutrition Research Institute-Department of Science and Technology (FNRI-DOST). Philippine Nutrition Facts and Figures 2018: Health and Nutritional Status of Filipino Adults. Manila, Philippines: FNRI Bldg; 2019.
-
- Whelton PK, Carey RM, Aronow WS, et al. . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71:2275–9. - PubMed
-
- Katz AM. Pharmacology and mechanisms of action of calcium-channel blockers. J Clin Hypertens 1986;2: (3 Suppl): 28S–37S. - PubMed
-
- Kes S, Caglar N, Canberk A, et al. . Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Curr Med Res Opin 2003;19:226–37. - PubMed
